Deutsche Bank
NMTR

Deutsche Bank’s 9 Meters Biopharma NMTR Stock Holding History

Deutsche Bank’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,741
Closed -$81K – 4407
2022
Q1 		$81K Sell
6,741
-730
-10% -$9.97K ﹤0.01% 3656
2021
Q4 		$146K Sell
7,471
-46,460
-86% -$1.04M ﹤0.01% 3525
2021
Q3 		$1.4M Sell
53,931
-104,363
-66% -$2.46M ﹤0.01% 2392
2021
Q2 		$3.48M Buy
158,294
+151,878
+2,367% +$3.73M ﹤0.01% 1771
2021
Q1 		$150K Buy
6,416
+4,569
+247% +$140K ﹤0.01% 3782
2020
Q4 		$32K Hold
1,847
– – ﹤0.01% 4194
2020
Q3 		$30K Buy
+1,847
New +$22.4K ﹤0.01% 4050
2020
Q2 		– Sell
-159
Closed -$2K – 4521
2020
Q1 		$2K Sell
159
-979
-86% -$12.3K ﹤0.01% 4227
2019
Q4 		$12K Buy
1,138
+949
+502% +$15.8K ﹤0.01% 4458
2019
Q3 		$4K Sell
189
-77
-29% -$1.56K ﹤0.01% 4712
2019
Q2 		$5K Sell
266
-1,060
-80% -$31.8K ﹤0.01% 5101
2019
Q1 		$49K Buy
1,326
+14
+1% +$605 ﹤0.01% 4567
2018
Q4 		$59K Sell
1,312
-789
-38% -$58.5K ﹤0.01% 4422
2018
Q3 		$287K Buy
2,101
+279
+15% +$47.9K ﹤0.01% 4072
2018
Q2 		$859K Buy
1,822
+128
+8% +$47.1K ﹤0.01% 3534
2018
Q1 		$927K Buy
+1,694
New +$330K ﹤0.01% 3357
2017
Q3 		– Sell
-22
Closed -$2K – 5159
2017
Q2 		$2K Buy
+22
New +$3.07K ﹤0.01% 4838

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Curi Wealth Management Raleigh, North Carolina $724M AUM 17.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Deutsche Bank's NMTR Position: Q2 2022 in Review

Deutsche Bank sold out of 9 Meters Biopharma (NMTR) in Q2 2022, closing a stake of 6,741 shares — an estimated $81K sold.

Deutsche Bank first reported a position in NMTR in Q2 2017 and held it in 17 quarters. The position peaked at $3.48M in Q2 2021. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • Deutsche Bank reported no remaining 9 Meters Biopharma position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 6,741 9 Meters Biopharma shares in Q2 2022, an estimated $81K.
  • Deutsche Bank first reported a position in 9 Meters Biopharma in Q2 2017 and held it in 17 quarters.
  • Deutsche Bank's 9 Meters Biopharma position peaked at $3.48M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.